Friday Jun 12 | Geriatrics
Inflammatory pathway to diabetes may be interrupted by salicylates
Salsalate may represent a novel treatment to lower blood glucose in patients with type 2 diabetes.
Researchers tap veterans at Carl T. Hayden Foundation
Research into medication and treatment of Type 2 diabetes, cardiovascular disease and other diseases is under way at a facility not typically associated with innovative research.
[Article] Nuclear Factor-{kappa}B Activation Contributes to Vascular...
Circulation. 2009 Published online before print February 23, 2009, doi: 10.1161/CIRCULATIONAHA.108.804294 Submitted on July 2, 2008 Accepted on November 4, 2008 Nuclear Factor- B Activation Contributes to ...
Old drug gets new life treating Type 2 diabetes
Dr. Kieren Mather is an associate professor of medicine at the Indiana University School of Medicine.
Ask The Pharmacist: Medical news you can use
The last few months of medical news has provided some outstanding studies. Read on for some interesting odds and ends that may impact your health.
National Institutes of Health (NIH) N...
Study Tests Anti-Inflammatory Drug for Poorly Controlled Type 2 Diabetes
Researchers in 20 medical centers across the country are enrolling adults with type 2 diabetes who have poorly controlled blood glucose to participate in a clinical study, Targeting Inflammation with Salsalate ...
Researchers Eye New Treatment For Type 2 Diabetes
There's a promising development in the treatment of type 2 diabetes. Local researchers are investigating whether an inexpensive arthritis drug can help diabetics.
Doctors have turned back the clock more than 100 years to rediscover a drug that can help the more than 15 million people in the United States with type 2 diabetes.